SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Aqua Metals, Inc. engages in reinventing metal recycling technologies. Its patented technology, AquaRefining, replaces polluting furnaces and hazardous chemicals with electricity-powered electroplating to recover valuable metals and materials from spent batteries with higher purity, lower emissions, and minimal waste. The company was founded by Stephen R. Clarke, Thomas Murphy, and Selwyn Mould on June 20, 2014 and is headquartered in Reno, NV.

Aqua Metals Inc

Aqua Metals ($AQMS) is trending as traders discuss its potential for a continued squeeze, citing its low float and positioning in the critical metals sector. Some community members are drawing parallels to similar stocks, suggesting further upward momentum, while others caution about the minerals/metals hype potentially nearing its end. The discussion also encompasses the company's potential role in addressing rare earth scarcity, amplifying investor interest.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. TeraWulf will generate domestically produced bitcoin powered by nuclear, hydro and solar energy. The company was founded by Paul Prager and Nazar Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

Fueled by expansion plans and potential AI/HPC growth, TeraWulf is trending as the community anticipates a possible short squeeze. Discussions revolve around key price levels, analyst price targets, and the stock's potential to follow similar runs seen in the AI data center space. Some investors are noting Google's backing as a key factor for long-term growth.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines ($LUNR) is trending as the community speculates about upcoming earnings and the potential for future lunar missions, with some eyeing profit-taking strategies. Chatter suggests a possible leak of significant news or contract awards related to the Lunar Terrain Vehicle (LTV). Community members are actively discussing the stock's recent gains and potential resistance levels.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

NVTS is surging due to progress on its 800V GaN and SiC power devices for NVIDIA's AI factory computing platforms, sparking excitement about its role in AI infrastructure. The community is closely watching for a potential short squeeze, with many expressing bullish sentiment and targeting higher price levels. Some investors are debating whether to chase the rally or wait for a pullback.

SEALSQ Corp. is a holding company, which engages in the security of microcontrollers. It operates through the following geographical segments: North America, Europe, Middle East, Africa, Asia Pacific, and Latin America. It focuses on authentication process, digital certification, and covering individual patents of semiconductors. The company was founded on April 1, 2022 and is headquartered in Cointrin, Switzerland.

SEALSQ Corp

SEALSQ ($LAES) is trending as investors discuss its potential in quantum-resistant security, fueled by recent partnerships in finance, energy, and defense. Community members are actively speculating on a potential short squeeze and significant price appreciation, while highlighting the company's growing role in securing sensitive data across various sectors. Discussions also include the relationship with parent company WKEY and upcoming catalysts such as the QAI conference.

Nova Minerals Ltd. engages in the exploration and development of mineral properties. Its projects include Estelle Gold, RPM, Korbel, Train, Stoney and Studies projects. The company was founded in January 1987 and is headquartered in Melbourne, Australia.

Nova Minerals Limited - ADR

Nova Minerals is trending due to increased interest in critical minerals and a potential meeting with former President Trump to discuss the company's projects. The community is focused on the possibility of a short squeeze and speculation surrounding the company's gold and antimony deposits. An offering and recent price volatility has also spurred discussion.

American Battery Technology Co. is a technology company, which engages in the development and marketing of lithium-ion batteries. Its projects include recycling plant, United States Advanced Battery Consortium (USABC), and Tonopah flats. The company was founded on October 6, 2011 and is headquartered in Reno, NV.

American Battery Technology Company

American Battery Technology Company is trending as community members discuss its recent surge, fueled by progress at its Tonopah Flats Lithium Project. Investors are optimistic about the company's potential role in U.S. lithium independence and are actively speculating on upcoming milestones like the Pre-Feasibility Study. The conversation also highlights the broader context of government initiatives supporting domestic battery material production.

Greenwave Technology Solutions, Inc. is an emerging growth company, which engages in recycling ferrous metal. It also recycles nonferrous metals including aluminum, copper, stainless steel, nickel, brass, titanium, lead, alloys, and mixed metal products. The company was founded on April 26, 2013 and is headquartered in Chesapeake, VA.

Greenwave Technology Solutions Inc

GWAV is trending as traders discuss potential short squeezes and its low float. Community members are pointing to the stock's potential for a breakout, while others caution about its history of dilution and financial standing. The stock is also gaining attention in relation to sympathy plays with other names in the sector.

Walmart, Inc. engages in the retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following business segments: Walmart U.S., Walmart International, and Sam's Club. The Walmart U.S. segment operates as a mass merchandiser of consumer products, operating under the Walmart and Walmart Neighborhood Market brands, including walmart.com. The Walmart International segment includes operations of wholly-owned subsidiaries in Canada, Chile, China, and Africa, and majority-owned subsidiaries in India, as well as Mexico and Central America. The Sam's Club segment manages membership-only warehouse clubs and operates samsclub.com. The company was founded by Samuel Moore Walton and James Lawrence Walton on July 2, 1962 and is headquartered in Bentonville, AR.

Walmart Inc

Walmart is trending as investors discuss its potential breakthrough to all-time highs, fueled by a robust e-commerce strategy and AI initiatives like the Sparky shopping assistant. Community members are weighing whether the stock's premium valuation is justified amidst strong fundamentals and growth prospects. Discussions also involve the company's strategic partnerships, including collaborations with OpenAI and Klarna, and their potential impact on Walmart's market position.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst is trending due to a recent acquisition announcement that has sparked mixed reactions among investors; while the company touts the strategic benefits of expanding their HAE portfolio, concerns about the acquisition's cost, potential dilution, and increased debt are prevalent. The community is actively debating whether this move signals a departure from previous strategies and what it means for future shareholder value, with some expressing frustration over the stock's continued decline. Discussions also involve the implications for competition and the company's long-term growth prospects within the rare disease sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of <a href="https://stocktwits.com/symbol/BJDX">Bluejay Diagnostics, Inc.&nbsp;(BJDX)</a> garnered heavy attention among retail investors on Stocktwits late Monday after the company raised money through a warrant deal from institutional investors.The stock, which more than doubled in the regular session, plunged nearly 50% in extended trading, with volume surging to more than 1,400 times its daily average.The Acton, Massachusetts-based company said it had secured approximately $3.7 million in gross proceeds after institutional investors agreed to exercise existing warrants for 1,085,106 shares at a reduced price of $3.42 per share.&nbsp;In return, the company issued new five-year warrants to purchase the same number of shares at the same price.Bluejay said it conducted the transaction under a private placement exemption.On Stocktwits, Bluejay was among the top trending tickers as of 9:40 pm ET, with retail chatter exploding by over 13,000% in the 24 hours to Monday evening.Sentiment on the platform was ‘extremely bullish’ even as the stock was sliding in after-hours trading.<figure class="image"><img style="aspect-ratio:1318/316;" src="https://news.stocktwits-cdn.com/BJDX_sentiment_and_message_volume_as_of_April_7_png_35f9b0019d.webp" alt="BJDX sentiment and message volume as of April 7.png" width="1318" height="316"><figcaption>BJDX sentiment and message volume as of April 7. | source: Stocktwits</figcaption></figure>One optimistic watcher said long traders on the stock were bracing for it to nearly double to $10 or even go as high as $15, speculating that there could be “big news” around the corner.<stembedurl>https://stocktwits.com/cjstocksup/message/610756719</stembedurl>Another expects the stock to retest the $5.25 level on Tuesday and said they would buy more if it drops below $3.50.<stembedurl>https://stocktwits.com/JamesTek2025/message/610813909</stembedurl>However, some users advised caution, given Bluejay’s low float of about 553,000 shares and&nbsp;the&nbsp;recent 1-for-50 reverse split in November.Bluejay has shifted focus away from COVID-19-related applications due to declining hospitalizations.It is now developing rapid, whole-blood tests on its patented Symphony platform, which includes a handheld device and single-use cartridges. Bluejay's lead product, the IL-6 test, targets inflammation and sepsis monitoring. The company recently completed a pilot study and plans to launch a follow-up trial to support FDA clearance.However, Bluejay said in November that it anticipates delays in submitting its FDA application within the next 18 months due to ongoing technical issues with its cartridge system.&nbsp;The company also expressed substantial doubt about its ability to continue as a going concern in 2025, citing the need for additional capital.Bluejay’s stock has gained over 60% this year.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Bluejay Diagnostics Raises $3.7M Through Warrant Deal, Stock Slides After-Hours While Retail Interest Surges

On Stocktwits, Bluejay was among the top trending tickers late Monday, with retail chatter exploding by over 13,000%.

Equity

Bluejay Diagnostics (NASDAQ:BJDX) and PetVivo (NASDAQ:PETV) Head-To-Head Review

Bluejay Diagnostics (NASDAQ:BJDX  Get Free Report) and PetVivo (NASDAQ:PETV  Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare...

Bluejay Diagnostics, Inc. (NASDAQ:BJDX) Short Interest Up 78.3% in February

Bluejay Diagnostics, Inc. (NASDAQ:BJDX  Get Free Report) was the recipient of a large increase in short interest in February. As of February 29th, there was short interest totalling 24,600...

Bluejay Diagnostics Announces Closing of $3.5 Million Public Offering

ACTON, Mass., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) ( Bluejay or the Company ), a medical technology company developing rapid diagnostics on its Symphony...

Bluejay Diagnostics, Inc. operates as a diagnostic company. It develops and markets minimally-invasive Point-of-Care diagnostics tests and devices that provide patients and providers with access to affordable and timely healthcare. It focus is on the infectious disease, inflammation, and oncology markets. The company was founded by Svetlana Dey and Dey Indraneil on March 20, 2015 and is headquartered in Acton, MA.

Bluejay Diagnostics Inc

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

Current Price	$3.74
Prev Close	$2.85
Open	$3.02
Dividend Yield	0.00%
50-Day Moving Average	$1.59
Beta	0.48
Avg. Volume	123,442.29
PE Ratio	-0.07

52-Week High	$12.45
52-Week Low	$1.26
Market Capitalization	$4.26M
EPS (Annual)	-$114.19
Price to Book	0.81
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

BJDX
Bluejay Diagnostics Inc

Feed

News

Sentiment

Fundamentals

Info

Latest BJDX News

BJDXBluejay Diagnostics Inc